Donald Kohn

Awards as PI
Award Value
Disease Team Research I Stem Cell Gene Therapy for Sickle Cell Disease $8,834,129
Early Translational IV Beta-Globin Gene Correction of Sickle Cell Disease in Hematopoietic Stem Cells $1,652,076
Disease Team Therapy Development III Clinical Trial of Stem Cell Gene Therapy for Sickle Cell Disease $13,145,465
Total:
$23,631,670.00
Videos